Details for Patent: 4,179,507

Summary for Patent: 4,179,507

Title:	Quarternary ammonium compounds
Abstract:	Compounds of formula (I): ##STR1## wherein Z1 and Z2 are the same or different and each represents a methylenedioxy substituent, or up to three methoxy substituents;R2 and R3 are the same or different and each is alkyl having 1-3 carbon atoms, prop-2-enyl or prop-2-ynyl;R4 and R5 are the same or different and each is a benzyl or phenethyl group wherein the phenyl ring is optionally substituted by one or more of halogen, alkoxy having 1 to 3 carbon atoms and methylenedioxy;A and B are the same or different and each is an alkylene radical containing 1,2, or 3 carbon atoms;L is an alkylene chain having from 2 to 12 carbon atoms or is a group --L1.0.L2 -- wherein each of L1 and L2 is alkylene having at least two carbon atoms and taken together L1 and L2 having up to 11 carbon atoms; andX- is an anion;may be used to effect neuromuscular paralysis in mammals.
Inventor(s):	John B. Stenlake, Roger D. Waigh, George H. Dewar, John Urwin, Nirmal C. Dhar
Assignee:	SmithKline Beecham Corp
Application Number:	US05/749,174
Patent Claim Types: see list of patent claims	Use; Composition; Formulation;

Drugs Protected by US Patent 4,179,507

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

Foreign Priority and PCT Information for Patent: 4,179,507

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
United Kingdom	50589/75	Dec 10, 1975
United Kingdom	45028/76	Oct 29, 1976

International Family Members for US Patent 4,179,507

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	365579
Austria	A908476
Australia	2037576
Australia	506657
Belgium	849241
Canada	1075241
Switzerland	625223